Navigation Links
Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
Date:3/23/2009

Results from the "NEXT" Study Also Showed Arzoxifene Significantly Suppressed Bone Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis

ATHENS, Greece, March 23 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) presented new data showing arzoxifene, an investigational selective estrogen receptor modulator (SERM), was superior to raloxifene at increasing bone mineral density (BMD) in the lumbar spine, total hip and femoral neck, and at suppressing bone turnover as assessed by serum markers of bone metabolism. In this study of 320 patients, more women reported bronchitis and nasopharyngitis in the arzoxifene group versus the raloxifene group, whereas significantly fewer women reported new or worsening hot flushes in the arzoxifene group. The data were presented at the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) annual meeting.

Arzoxifene is being studied for the prevention and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive breast cancer in postmenopausal women with osteoporosis or low bone mass.

About the "NEXT" Study

Arzoxifene versus Raloxifene: 12-month Effects on Bone Mineral Density, Bone Turnover Markers, and Safety Parameters in Postmenopausal Women with Osteoporosis

This Phase III trial, powered to show superiority, was a double-blind, active comparator, controlled, 12-month study. In the study, 320 postmenopausal women with osteoporosis were randomized to receive arzoxifene 20 mg/day (N= 158) or raloxifene hydrochloride 60 mg/day (N= 162). In addition, supplements containing 500 mg/day calcium and 400-600 IU/day vitamin D were provided. The study's primary endpoint was lumbar spine BMD. Secondary objectives included assessment of femo
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
2. Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients
3. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
4. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
5. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
6. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
7. Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
8. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
9. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
11. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015 Bayer HealthCare announced today ... Conquer Cancer Foundation of the American Society of Clinical ... information technology platform designed to unlock vast quantities of ... "Bayer is proud to join ASCO ... leverage Big Data to help people whose lives have ...
(Date:3/5/2015)... NEW YORK , March 5, 2015 /PRNewswire/ ... real-time patient management solutions recognized for improving the ... announced today that Robert Anazagasty and ... Anazagasty will serve as Vice President, Strategic Client ... Enterprise Sales. These additions support AMC Health,s commitment ...
(Date:3/5/2015)... , March 5, 2015 LUNGevity ... the Food and Drug Administration,s (FDA) approval of ... Opdivo and other immunotherapy treatments add another critical ... harnessing the power of a patient,s own immune ... has been approved specifically for patients with squamous ...
Breaking Medicine Technology:Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
... 23, 2012  AlloSource, one of the nation,s largest non-profit ... use in surgical procedures and the world,s largest processor ... Dale Bike as Vice President of Sales and Marketing. ... Sales and Marketing, Dale will lead the AlloSource direct ...
... The Academy of Managed Care Pharmacy (AMCP) has installed ... elected members: President-Elect Kim A. Caldwell and Directors David ... members on the new Board of Directors are: President ... Directors Steve Avey and Eric Cannon. All of the ...
Cached Medicine Technology:Industry Veteran Brings Sales Expertise to AlloSource's Growing Distribution Network 2Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors 2Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors 3Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors 4
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned a verdict ... plaintiff Coleen M. Perry a total of $5.7 million for ... mesh sling device, manufactured by Ethicon, Inc., a subsidiary of ... at Wagstaff & Cartmell in Kansas City, Mo., ... Rich Freese and Tim Goss of Freese & Goss ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to announce ... logo and optimized website. , CNI’s new ... expert diagnostic imaging, centered on patient care. The new ... a resource for Nebraska patients and a tool for ... referral functionality, video content and resources to understand health ...
(Date:3/5/2015)... 05, 2015 On March 2, 2015, ... Labiaplasty on the Rise, Plastic Surgeons Say,” that comments ... Society for Aesthetic Plastic Surgery and the ... reported a year-over-year doubling of surgical butt augmentations performed ... in the article, this increase can be attributed to ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 At the ... and Beyond,” leaders in addiction treatment met today in ... in best clinical practices. Among the numerous respected speakers ... who will address the role that pain medications have ... new evidence-based treatment options. , "It is hard to ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 University ... university founded in 1904, has launched a new ... positive lifestyle changes. The Northwest Center for Lifestyle ... professionals, support community outreach, and conduct research in ... medicine, diet and nutrition. The center will target ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... Valentine,s Day gifts that truly demonstrate couple,s loveATLANTA, Feb. ... for couples to express their love for one another, ... convey this important message. But one pair of unique ... commitment to each other. This Valentine,s Day couples can ...
... MI based manufacturer of industrial parts cleaning systems and custom ... field. Midbrook’s Cart Washer for Central Processing was ... for Central Processing is a large capacity, fully automated, floor ... Processing Unit of hospitals. , ...
... consider supplemental insurance for ,critical illness coverage , ... Chicago (PRWEB) February ... their first heart attack in 2009 and, on average, every 40 seconds ... is a good time to consider not just your risk for heart ...
... dentists will give over 350 children a new smile! , ... (PRWEB) ... 350 children a new smile! The opportunity comes at a perfect ... Kentucky! , a community partnership that addresses the most common unmet health ...
... , ... Ann Arbor, MI (PRWEB) February 4, 2009 ... applications, announces revenue increased year-over-year by over 300 percent in 2008. ... base of clinician users by over 400 percent over the previous ...
... Niche, Healthcare-Career Site Recognized by Candidate Community , ... ... onTargetjobs Inc. (OTJ) company and North America,s premier healthcare ... named as this year,s top job sites., , , , ,"With ...
Cached Medicine News:Health News:When Flowers or a Tie Just Won't Do 2Health News:Midbrook Installs New Cart Washer for Central Processing in Local Hospital 2Health News:Know Your Risk and Insurance Coverage for Heart Attacks and Strokes 2Health News:Know Your Risk and Insurance Coverage for Heart Attacks and Strokes 3Health News:A New Smile: During Tough Economic Conditions Hundreds of Kentucky Children Receive Free Dental Care 2Health News:A New Smile: During Tough Economic Conditions Hundreds of Kentucky Children Receive Free Dental Care 3Health News:Cielo MedSolutions Announces Strong Revenue Growth in 2008 2Health News:HEALTHeCAREERS Network Receives WEDDLE's 2009 User's Choice Award 2
Wire mesh braided design with a platinum core....
... Finnpipette Focus multichannel pipettes ... of reagents into microplates, ... 0.1-10 l volumes. The ... Finnpipette Focus multichannels, combined ...
... The Finnpipette Digital Multichannel, ... even lighter work of routine ... all these advanced features: Soft-touch ... micro volume pipetting (0.5-10ul models), ...
... and Benefits: 1-12channel pipette This ... product number, created to easily ... showing no availability yet, please ... number (Z37,173-4) or contact customer ...
Medicine Products: